IMUGENE LIMITED

3.45%

14.0¢

Market Cap $51.76M

Healthcare Biotechnology

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

PIONEER LITHIUM

Pioneer Minerals (ASX: PMM) stands as a leading Australian exploration firm spearheading lithium exploration and development within Canada.

Latest Threads

Tag

Subject

IMU

Ann: Notification of cessation of securities - IMU

15:50

3.1K

15:50

Last post sookycoopoops

3.1K

IMU

Media Thread

325 326 327

12/04/26

19K

9.4M

12/04/26

Last post Lcwallerdurack

19K

9.4M

IMU Biotech

IMUGENE CHART. TA only

650 651 652

11/04/26

39K

20M

11/04/26

Last post mumstheword

39K

20M

IMU

Why IMU is a multi multi bagger

554 555 556

11/04/26

33K

17M

11/04/26

Last post Footmax

33K

17M

IMU

Ann: 100% and 80% ORRs in Subset Indications in azer-cel study

10/04/26

112

33K

10/04/26

Last post Marv1n

112

33K

IMU

Ann: Application for quotation of securities - IMU

08/04/26

584

08/04/26

Last post

ASX News

584

IMU

Imugenes next move

06/04/26

8.6K

06/04/26

Last post PlayMoney76

8.6K

IMU

LESLIE CHONG NEEDS TO TAKE A PAY CUT

2 3

05/04/26

156

45K

05/04/26

Last post MrLearner

156

45K

See All Discussions

Timeline

Notification of cessation of securities - IMU
10 Apr 16:15	Share

Application for quotation of securities - IMU
08 Apr 16:15	Share

Notification regarding unquoted securities - IMU
02 Apr 16:56	Share

Appendix 2A
01 Apr 16:42	Share

Azer-cel data to be presented at 2026 ASCO Annual Meeting
01 Apr 09:46	Share

Notice of Extraordinary General Meeting/Proxy Form
23 Mar 10:02	Share

Cleansing Notice
20 Mar 09:37	Share

Application for quotation of securities - IMU
20 Mar 09:29	Share

Notification regarding unquoted securities - IMU
19 Mar 17:34	Share

Application for quotation of securities - IMU
19 Mar 17:32	Share

Update - Proposed issue of securities - IMU
19 Mar 11:54	Share

Update - Proposed issue of securities - IMU
19 Mar 10:35	Share

Prospectus
17 Mar 17:44	Share

Notification regarding unquoted securities - IMU
12 Mar 16:07	Share

Application for quotation of securities - IMU
12 Mar 16:05	Share

Imugene Capital Raising Presentation
11 Mar 13:45	Share

Proposed issue of securities - IMU
11 Mar 13:35	Share

Proposed issue of securities - IMU
11 Mar 13:35	Share

$20M placement and SPP, convertible notes amended
11 Mar 13:35	Share

100% and 80% ORRs in Subset Indications in azer-cel study
10 Mar 10:03	Share

Trading Halt
10 Mar 09:12	Share

Imugene to Present at TD Cowen Annual Health Care Conference
27 Feb 09:54	Share

Imugene Receives $2.7M R&D Tax Refund
25 Feb 12:52	Share

Half Yearly Report and Accounts
25 Feb 12:37	Share

Notice of Expiry of Listed Options
24 Feb 17:50	Share

Notification regarding unquoted securities - IMU
20 Feb 16:14	Share

Application for quotation of securities - IMU
16 Feb 16:12	Share

Cleansing Notice
30 Jan 16:19	Share

Application for quotation of securities - IMU
30 Jan 16:09	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jan 09:30	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 14.0¢		Change -0.005(3.45%)		Mkt cap ! $51.76M

Open	High	Low	Volume
15.0¢	15.0¢	14.0¢	865.4K

Buyers (Bids)

Vol.	Price($)
13147	15.0¢

Sellers (Offers)

Price($)	Vol.
12.5¢	332

Last trade - 16.00pm 13/04/2026 (20 minute delay)

IMU (ASX) Chart

IMUGENE LIMITED

Latest Threads

From construction to cashflow: PL9 locks in offtake + first production in sight

Timeline

Featured News

Latest Videos

Imugene (ASX:IMU) doses first patients in VAXINIA combination study

03 Mar 2023 14:39 (AEDT)

Imugene (ASX:IMU) receives US patent for PD1-Vaxx

10 Feb 2023 10:58 (AEDT)

Imugene (ASX:IMU) advances VAXINIA trial

02 Feb 2023 12:21 (AEDT)

Latest Articles

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

The ASX has headed into a downturn this Wednesday, mostly thanks to U.S. CPI data from June suggesting Trump’s tariffs are finally having an impact on inflation, but that hasn’t stopped several companies flying on the forums.Listen to the HotCopper podcast for in-d...

Yes, we burn a lot of cash: Imugene issues letter to investors as 1Y returns -72%

As it clocks one year returns down -72%, Imugene Ltd (ASX:IMU) this week issued a letter to shareholders confirming shareholders'...

First Aussie doses bring Imugene major step closer to 'quicker, cheaper' non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic CAR T-cell therapy Azer-cel treatment at the Royal Prince Alfred Hospital in Sydney earlier this week.This dosage marks the start of Imugene’s Phase 1b t...

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News